SAP S/4HANA, SAP C/4HANA suite, SAP Analytics Cloud, and SCI platform power the modular solution by Infosys for pharmaceutical companies to utilise.
Indian multinational company Infosys brings a groundbreaking solution that would further advance the pharmaceutical industry. As a global leader in next-generation digital services and consulting, the company intends to digitise processes, streamline the supply chain, and deliver personalised patient experience for pharmaceutical companies worldwide.
The modular solution, known as the Infosys Personalized Medicine Solution, leverages intelligent solutions such as SAP S/4HANA, SAP C/4HANA suite, SAP Analytics Cloud, and SCI platform. With this technology integration, pharma companies can derive intelligent insights that would empower them to resolve critical business challenges and regulatory requirements as well as deliver personalised patient experience.
Driving Business Outcome and Patient Experience
Aside from digitally transforming processes and helping companies achieve their bottom line, more importantly; the Infosys Personalized Medicine Solution can manage individual patient treatment lifecycle from enrollment and scheduling to post medical treatments by using advanced analytics. Consequently, it can notably reduce the patient treatment lifecycle.
Moreover, the Infosys solution takes advantage of blockchain and IoT in managing critical cold chains and outcome-based invoicing. Pharmaceutical companies can accelerate product launches with the intelligent solution’s capability to seamlessly integrate into an existing business process with minimal disruptions and reduction in implementation time.
“With rapid growth in digital technologies and advances in biology, the personality
ed medicine market is projected to grow significantly, and we see a huge opportunity in this space,” said Subhro Mallik, SVP & Global Head of Life Sciences at Infosys.
“Digital technologies can help pharma companies accelerate their time to market and provide better patient experiences. Our Personalized Medicine Solution, leveraging SAP S/4HANA, will help ensure that traditional pharma companies are able to digitally transform themselves with minimum disruption,” Mallik added.
Saurabh Gupta, Chief Research Officer at the business analytics company HfS Research shared that the top strategic objective across the healthcare and life sciences industry today is consumer-centricity, which aligns with the new Infosys solution’s objective. He shared:
“ I am most excited about the personalised comprehensive visibility and transparency that this solution from Infosys and SAP offers to the patient by bringing together the complex network of entities (payer, provider, and pharma) that they have to deal with.”
SAP S/4HANA as the Digital Core
Joe Miles, SVP and Head of HCLS Business Unit at SAP, emphasised how pharmaceutical companies leverage SAP’s next-generation, intelligent ERP business suite SAP S/4HANA in driving new therapeutic models like the Personalised Medicine. Miles explained:
“To make this possible, life sciences leaders are disrupting their business models and supply chains to successfully deliver these life-saving and individualised therapies. Organisations must evolve from a traditional “make to stock” model to a highly personalised “make to order” model. This requires aggregating and analysing massive amounts of genomic, therapeutic, and patient data, in real-time, to execute an end-to-end process, at scale.”
On SAP S/4HANA as an intelligent solution and with SAP’s partnership with Infosys, Miles elaborated:
“SAP S/4HANA provides a digital core to help enable the intelligent life sciences enterprise and deliver these remarkable drugs and devices. The partnership of SAP S/4HANA with Infosys’ Personalized Medicine Solution will allow organisations to leverage their SAP S/4HANA digital core investments, combined with Infosys’ thought-leading expertise, to enable our customers’ growth and scale in this new market.”
Headquartered in Bengaluru, India, Infosys Limited has a presence in 46 countries with over 242,000 employees. For almost four decades of experience in managing the systems and workings of a global enterprise, the company has helped over 1,400 customers accelerate their digital transformation.
Infosys has been awarded the number 3 ranking on the Forbes list of The World’s Best Regarded Companies for 2019.